Sign In
Buy RAD
$0.648
+0 (+0%)
At Close: Jan 12, 2024
Top 5 Risk Off Stocks That You May Want To Dump In Q1 2023
12:19pm, Thursday, 23'rd Feb 2023 Benzinga
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days
Best Penny Stocks This Week? 4 Short Squeeze Stocks To Watch
12:35pm, Wednesday, 22'nd Feb 2023
Short interest is high on these penny stocks. Time to buy or avoid them entirely?
4 Penny Stocks To Watch With High Short Interest In January 2023
12:14pm, Friday, 27'th Jan 2023
Are these penny stocks ready to squeeze? The post 4 Penny Stocks To Watch With High Short Interest In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon
01:39pm, Wednesday, 25'th Jan 2023 Zacks Investment Research
CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon are part of the Zacks Industry Outlook article.
Is Amazon the Future of Healthcare?
11:15am, Wednesday, 25'th Jan 2023 The Motley Fool
The e-commerce titan announced the RxPass subscription for Prime members. What companies will this service disrupt, and can Amazon stock benefit?
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
01:07pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
09:47am, Tuesday, 24'th Jan 2023
The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.
Why Is Rite Aid (RAD) Down 7% Since Last Earnings Report?
04:30pm, Friday, 20'th Jan 2023 Zacks Investment Research
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
03:21pm, Friday, 20'th Jan 2023 Benzinga
Here's a round-up of stories from around the globe and from various media outlets.
Benzinga
Google To Fire 12K Employees Worldwide; Extends Support Packages
Alphabet Inc.'s (NASDAQ: GOOG) (NASDAQ: G
Why Is Rite Aid (RAD) Down 7% Since Last Earnings Report?
12:47pm, Friday, 20'th Jan 2023
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?
C-Suite Transitions: Rite Aid CEO Departs Abruptly
05:38pm, Thursday, 12'th Jan 2023
Rite Aid Corporation is a name that is very familiar to arbitrageurs because of its history of failed mergers. Rite Aid recently announced that Heyward Donigan, the company's President and Chief Execu
Can Rite Aid (RAD) Get Back on Track Via Solid Growth Efforts?
04:26pm, Thursday, 12'th Jan 2023 Zacks Investment Research
Rite Aid (RAD) is reeling under elevated expenses. Yet, online strength, led by expanded delivery services, increased non-COVID prescriptions, and cost-saving initiatives, are likely to aid.
Can Rite Aid (RAD) Get Back on Track Via Solid Growth Efforts?
12:48pm, Thursday, 12'th Jan 2023
Rite Aid (RAD) is reeling under elevated expenses. Yet, online strength, led by expanded delivery services, increased non-COVID prescriptions, and cost-saving initiatives, are likely to aid.
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
01:24pm, Tuesday, 10'th Jan 2023 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. I can not like binar
Rite Aid announces Heyward Donigan exit, appointment of interim CEO
07:25pm, Monday, 09'th Jan 2023
Rite Aid experienced a leadership shakeup as the pharmacy change announce CEO Heyward Donigan's exit and the appointment of an interim chief executive.
